Review: Postmenopausal estrogen replacement therapy increases the risk for venous thromboembolism

Douketis, James
September 2002
ACP Journal Club;Sep/Oct2002, Vol. 137 Issue 2, p42
Academic Journal
Presents a systematic review and meta-analysis concerning postmenopausal estrogen replacement and the risk of venous thromboembolism. Thromboembolic events in postmenopausal women receiving hormone replacement therapy (HRT) versus no HRT; Data sources for the review; Implications for postmenopausal estrogen replacement therapy.


Related Articles

  • Estrogen and Thromboembolic Disorders: Should Patients Stop Hormones Prior to Cosmetic Surgery? Shiffman, Melvin A. // International Journal of Cosmetic Surgery & Aesthetic Dermatolog;Sep2002, Vol. 4 Issue 3, p213 

    Oral contraceptives and replacement estrogenic hormones have been associated with a significant risk of thromboembolism. Cosmetic surgery consists of elective procedures in otherwise healthy individuals. The prospect of thromboembolism should be diminished in these patients by avoiding those...

  • Assessment of the Risk for Venous Thromboembolism Among Users of Hormone Replacement Therapy. Oger, E.; Scarabin, P-Y. // Drugs & Aging;1999, Vol. 14 Issue 1, p55 

    Although hormone replacement therapy (HRT) provides health benefits, concerns about harmful effects have been raised, including an increased risk of venous thromboembolism. The purpose of this review is to assess the risk for venous thromboembolism associated with HRT. Data searches involved the...

  • Oral, not transdermal, estrogens raise thromboembolism risk.  // Reactions Weekly;3/6/2010, Issue 1291, p3 

    The article discusses research being done on the effect of using oral estradiol congeners on the risk of idiopathic venous thromboembolism in postmenopausal women with reference to a study by M. Canonico and colleagues in the February 2010 issue of "Arteriosclerosis Thrombosis and Vascular Biology."

  • The French ESTHER Study of VTE. Speroff, Leon // OB/GYN Clinical Alert;May2007, Vol. 24 Issue 1, p6 

    The EStrogen and THromboEmbolism Risk (ESTHER) study is a case-control study performed with cases from 8 French hospitals and controls from the general population. The results were as follows: The authors concluded that transdermal estrogen is not associated with an increased risk of VTE, and...

  • A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability. Sven O. Skouby; Johannes J. Sidelmann; Lisbeth Nilas; Jørgen Jespersen // Human Reproduction;Apr2007, Vol. 22 Issue 4, p1186 

    BACKGROUND Hormone therapy (HT) after the menopause is associated with increased risk of venous thromboembolism (VTE). Tibolone has pharmacodynamic properties different from other hormone preparations. We compared the effect of a combined HT and tibolone on the inhibition of haemostasis. ...

  • Oral Contraceptives and Venous Thromboembolism: Which Are the Safest Preparations Available? Girolami, A.; Spiezia, L.; Rossi, F.; Zanon, E. // Clinical & Applied Thrombosis/Hemostasis;Apr2002, Vol. 8 Issue 2, p157 

    Oral contraceptive therapy is associated with a fourfold increased risk of venous thromboembolism as compared with age-matched non-users. The composition of oral contraceptives has varied considerably during the past two to three decades. The estrogen content (ethinylestradiol) has decreased and...

  • PRESCRIBED DRUGS AND NEUROLOGICAL COMPLICATIONS. Grosset, K.A.; Grosset, D. G. // Journal of Neurology, Neurosurgery & Psychiatry;Sep2004 Supplement 3, Vol. 75, piii2 

    This article discusses several prescribed drugs and toxicological complications. Current users of low oestrogen dose combined oral contraception have a small increased risk of ischaemic stroke, particularly in women with other risk factors, notably smoking, hypertension, and probably a history...

  • Understanding Hormone Action: Does Route of Administration Matter? Berga, Sarah L. // OB/GYN Clinical Alert;Jul2007, Vol. 24 Issue 3, p20 

    The article comments on the findings of the Estrogen and Thromembolism Risk (ESTHER) Study Group on the risk of women taking estradiol and estrogen via oral and transdermal administration to thromboembolism. It notes that the study has only two cases and no controls took conjugated equine...

  • Hormone therapy and VTE risk.  // Neurology Alert;Dec2012, Vol. 31 Issue 4, Special section p1 

    The article focuses on the venous thromboembolism (VTE) risk in menopausal hormone therapy (HT). It references a study published in the September 10, 2012 online issue of the "Journal of Thrombosis and Haemostosis." Findings from the Million Women Study showed varying risks of different HT...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics